aap Implantate AG (AAQ1.F)
- Previous Close
0.8800 - Open
0.8400 - Bid 0.8500 x --
- Ask 0.9900 x --
- Day's Range
0.8400 - 0.8400 - 52 Week Range
0.6500 - 1.4800 - Volume
12 - Avg. Volume
51 - Market Cap (intraday)
8.662M - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2700 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany, and through a network of distributors internationally. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
www.aap.deRecent News: AAQ1.F
Performance Overview: AAQ1.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AAQ1.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AAQ1.F
Valuation Measures
Market Cap
9.07M
Enterprise Value
9.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
0.61
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
-7.02
Financial Highlights
Profitability and Income Statement
Profit Margin
-19.32%
Return on Assets (ttm)
-11.28%
Return on Equity (ttm)
-17.22%
Revenue (ttm)
11.96M
Net Income Avi to Common (ttm)
-2.31M
Diluted EPS (ttm)
-0.2700
Balance Sheet and Cash Flow
Total Cash (mrq)
1.4M
Total Debt/Equity (mrq)
18.82%
Levered Free Cash Flow (ttm)
-1.8M
Company Insights: AAQ1.F
AAQ1.F does not have Company Insights